Shuichi Sakamoto
Chairman en Asahi Kasei Pharma Corp. .
Perfil
Shuichi Sakamoto is currently the Chairman at Asahi Kasei Pharma Corp.
He previously worked as a Director at Asahi Kasei Corp.
from 2016 to 2019.
Cargos activos de Shuichi Sakamoto
| Empresas | Cargo | Inicio |
|---|---|---|
Asahi Kasei Pharma Corp.
 Asahi Kasei Pharma Corp. Investment ManagersFinance Part of Asahi Kasei Corp., Asahi Kasei Pharma Corp. is a pharmaceutical and diagnostic company based in Tokyo, Japan. Asahi Kasei Pharma operates in the healthcare business unit of the Asahi Kasei Group, with a mission to sincerely care for each individual life and solve their unmet medical needs with a wealth of ideas and solid science. Asahi Kasei Corp. is a US $20 billion Japanese technology company that provides innovative, science-based solutions to a diverse range of markets including healthcare, chemicals and fibers, housing and construction materials, and electronics. Founded in 2003, the private company has developed innovative drugs in the fields of orthopedics, acute care, neurology (including pain), and immunology. | Chairman | 01/04/2018 |
Antiguos cargos conocidos de Shuichi Sakamoto.
| Empresas | Cargo | Fin |
|---|---|---|
| ASAHI KASEI CORPORATION | Director/Board Member | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ASAHI KASEI CORPORATION | Process Industries |
| Empresas privadas | 1 |
|---|---|
Asahi Kasei Pharma Corp.
Asahi Kasei Pharma Corp. Investment ManagersFinance Part of Asahi Kasei Corp., Asahi Kasei Pharma Corp. is a pharmaceutical and diagnostic company based in Tokyo, Japan. Asahi Kasei Pharma operates in the healthcare business unit of the Asahi Kasei Group, with a mission to sincerely care for each individual life and solve their unmet medical needs with a wealth of ideas and solid science. Asahi Kasei Corp. is a US $20 billion Japanese technology company that provides innovative, science-based solutions to a diverse range of markets including healthcare, chemicals and fibers, housing and construction materials, and electronics. Founded in 2003, the private company has developed innovative drugs in the fields of orthopedics, acute care, neurology (including pain), and immunology. | Finance |
- Bolsa de valores
- Insiders
- Shuichi Sakamoto
